Kim Paul J, Yang Phillip C
Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, USA.
Rev Recent Clin Trials. 2012 Aug;7(3):204-13. doi: 10.2174/157488712802281286.
Spurred by remarkable findings in animal studies, there has been strong interest in evaluating the potential of adult stem cells to improve left ventricular function in the past decade. Driven by the need to treat the increasing number of patients with coronary artery disease, numerous studies have attempted to define a role for bone marrow cell therapy in clinical use. However, the conflicting results of these studies can be confusing. This article will review the landmark trials evaluating bone marrow cell therapy in the past decade and describe the current state of adult stem cell therapy and its future direction herein.
在动物研究取得显著成果的推动下,过去十年间人们对评估成体干细胞改善左心室功能的潜力产生了浓厚兴趣。由于需要治疗越来越多的冠状动脉疾病患者,众多研究试图明确骨髓细胞疗法在临床应用中的作用。然而,这些研究相互矛盾的结果可能会令人困惑。本文将回顾过去十年评估骨髓细胞疗法的标志性试验,并阐述成体干细胞疗法的现状及其未来发展方向。